Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.23 USD | -7.57% | +9.30% | 0.00% |
Business Summary
Number of employees: 5
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 71 | 21-08-25 | |
Nathen Fuentes
DFI | Director of Finance/CFO | 41 | 23-09-20 |
Michelle Yanez
AUD | Comptroller/Controller/Auditor | 52 | 22-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 71 | 21-08-25 | |
Craig Eagle
BRD | Director/Board Member | 57 | 22-10-31 |
Talhia Tuck
BRD | Director/Board Member | 46 | 22-10-31 |
Brad Kroenig
BRD | Director/Board Member | 45 | 22-10-31 |
Hugh McColl
BRD | Director/Board Member | 63 | 22-10-31 |
Michelle Yanez
AUD | Comptroller/Controller/Auditor | 52 | 22-04-30 |
Michael Jerman
BRD | Director/Board Member | 40 | 10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 29,609,814 | 17,031,576 ( 57.52 %) | 0 | 57.52 % |
Company contact information
Telomir Pharmaceuticals, Inc.
855 North Wolfe Street Suite 601
21205, Baltimore
+
http://www.telomirpharma.comSector
1st Jan change | Capi. | |
---|---|---|
0.00% | 200M | |
+38.59% | 727B | |
-7.89% | 354B | |
+15.66% | 328B | |
+0.24% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+4.23% | 164B | |
-1.70% | 164B |
- Stock Market
- Equities
- TELO Stock
- Company Telomir Pharmaceuticals, Inc.